|Nigel Beeley is the CEO and Founder of Enrqi, Inc. From March 1999 through June 2004, Dr.Beeley served as Vice President, Chief Chemical Officer of Arena Pharmaceuticals,a biopharmaceutical company. From 1994 to 1998, Dr. Beeley was Senior Director of Chemistry at Amylin Pharmaceuticals, Inc., a biotechnology company, and,from 1988 to 1994, he served as Head of Oncology-Chemistry for Celltech,a biotechnology company. From 1980 to 1988, Dr. Beeley held positions of increasing seniority in the cardiovascular group at Synthelabo Research,a pharmaceutical company, and, from 1978 to 1980, he was a CNS medicinal chemist in the pharmaceutical division of Reckitt and Coleman, a conglomerate.From 1976 to 1978, Dr. Beeley held a Royal Society Overseas Research Fellow at ETH, Zurich, Switzerland. Dr. Beeley has a B.Sc. Honours (Class 1) degree in Chemistry from the University of Liverpool, U.K. and a Ph.D. in Chemistry from the University of Manchester, U.K.
Listen to an interview with Nigel about Biotech in China